- Conditions
- Acquired Bone Marrow Failure Syndromes, Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic/Undifferentiated/Prolymphocytic Leukemias, Burkitt Lymphoma, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Diffuse Large Cell Non Hodgkins Lymphoma, Follicular Lymphoma, High Grade Non-Hodgkin's Lymphoma, Adult, High Risk Anemia, Juvenile Myelomonocytic Leukemia, Lymphoblastic Lymphoma, Lymphoma, Lymphoplasmacytic Lymphoma, MRD Positive Leukemia, Mantle-Cell Lymphoma, Marginal Zone B-Cell Lymphoma, Multiple Myeloma, Myelodysplasia, Myelofibrosis, Myeloproliferative Neoplasms, Natural Killer Cell Malignancies, Plasma Cell Leukemia, Prolymphocytic Leukemia, Refractory Anemia, Small Lymphocytic Lymphoma
- Interventions
- HSCT with Non-TBI Regimen, HSCT with TBI Regimen
- Biological
- Lead sponsor
- Masonic Cancer Center, University of Minnesota
- Other
- Eligibility
- Up to 60 Years
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2028
- U.S. locations
- 1
- States / cities
- Minneapolis, Minnesota
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–1
of 1
matching trial from the local directory fallback.